These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8565751)

  • 1. Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience.
    Bianchi FB; Cassani F; Lenzi M; Ballardini G; Muratori L; Giostra F; Zauli D
    Dig Dis Sci; 1996 Jan; 41(1):166-71. PubMed ID: 8565751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
    Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
    Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis.
    Toda G; Zeniya M; Watanabe F; Imawari M; Kiyosawa K; Nishioka M; Tsuji T; Omata M
    J Hepatol; 1997 Jun; 26(6):1207-12. PubMed ID: 9210605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-organ specific autoantibodies associated with chronic C virus hepatitis.
    Abuaf N; Lunel F; Giral P; Borotto E; Laperche S; Poupon R; Opolon P; Huraux JM; Homberg JC
    J Hepatol; 1993 Jul; 18(3):359-64. PubMed ID: 8228130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GOR and hepatitis C virus in autoimmune liver diseases.
    Michel G; Ritter A; Gerken G; Meyer zum Büschenfelde KH; Decker R; Manns MP
    Lancet; 1992 Feb; 339(8788):267-9. PubMed ID: 1346282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.
    Omagari K; Masuda J; Kato Y; Nakata K; Kanematsu T; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Koga M; Yano M; Kohno S
    Intern Med; 2000 Dec; 39(12):1008-12. PubMed ID: 11197782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques.
    Muratori L; Cataleta M; Muratori P; Manotti P; Lenzi M; Cassani F; Bianchi FB
    J Immunol Methods; 1995 Dec; 187(2):259-64. PubMed ID: 7499885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis.
    Czaja AJ; Magrin S; Fabiano C; Fiorentino G; Diquattro O; Craxi A; Pagliaro L
    Dig Dis Sci; 1995 Jan; 40(1):33-40. PubMed ID: 7529673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection.
    Cassani F; Muratori L; Manotti P; Lenzi M; Fusconi M; Ballardini G; Selleri L; Volta U; Zauli D; Miniero R
    Gut; 1992 Sep; 33(9):1260-3. PubMed ID: 1330845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB; Taswell HF; Homburger HA
    J Hepatol; 1993 Jul; 18(3):342-52. PubMed ID: 8228128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune responses as assessed by hypergammaglobulinemia and the presence of autoantibodies in patients with chronic hepatitis C.
    Kawamoto H; Sakaguchi K; Takaki A; Ogawa S; Tsuji T
    Acta Med Okayama; 1993 Oct; 47(5):305-10. PubMed ID: 8273454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral lichen planus in patients infected or noninfected with hepatitis C virus: the role of autoimmunity.
    Carrozzo M; Gandolfo S; Lodi G; Carbone M; Garzino-Demo P; Carbonero C; Porter SR; Scully C
    J Oral Pathol Med; 1999 Jan; 28(1):16-9. PubMed ID: 9890452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-induced autoimmunity in hepatitis C virus infections: a rare event.
    McFarlane BM; Bridger C; Tibbs CJ; Saleh MG; Fuzio A; Verucchi G; Attard L; Boschi A; Chiodo F; McFarlane IG
    J Med Virol; 1994 Jan; 42(1):66-72. PubMed ID: 7508490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
    Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
    Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
    Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi FB; Mieli-Vergani G; Vergani D
    J Hepatol; 1997 Jun; 26(6):1396-402. PubMed ID: 9210629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions.
    Valentini G; Mantelli A; Persico M; Tuccillo C; Del Vecchio Blanco G; Morisco F; Improta RD; Migliaresi S; Gualdieri L; Caporaso N
    Clin Exp Rheumatol; 1999; 17(1):75-9. PubMed ID: 10084036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.